Skip to content

Autonomics and Orthostatic Hypotension

Emily Walsh


Background

  • Orthostatic Hypotension (OH): SBP ↓ > 20 mmHg, DBP ↓ > 10 mmHg), or HR Increase > 30 within 3 min of standing up or head-up tilt to 60% on a tilt table
  • Etiologies: Neurogenic OH (nOH) vs non-neurogenic OH
    • nOH associated with autonomic failure
      • Blunted tachycardia during hypotension characteristic of autonomic failure
      • nOH: If HR rise is \<15
      • nOH also associated with periods of high BP (supine hypertension)
      • Ex: Neurodegenerative disease, neuropathy (diabetes, amyloid, paraneoplastic, etc)
    • Other causes: volume depletion (most common), medications (diuretics, alpha-1 blockers, BB, etc), pump failure (severe AS, arrhythmia)

Evaluation

  • Orthostatic vitals signs (checking supine, sitting, and standing with 5-minute wait in each position)
  • Volume status exam
  • Labs: CBC, CMP, EKG, TSH, B12, , LFTs
  • Consider SPEP/UPEP, paraneoplastic panel, autonomic function testing depending on clinical context

Management

  • Conservative:

    • TED hose and abdominal binder for ambulation
    • Drink 16oz of fluid 15 min prior to standing
    • If they have supine HTN, keep HOB 30-45 degrees at all times
    • Add 2.3-4.6g of salt per day to diet (if no contraindications)
    • Avoid high temperatures (which cause peripheral vasodilation)
  • Pharmacologic therapies (see table):

Drug Dose Mechanism Side effects
Fludocortisone (Florinef)

0.1mg QD

↑ by 0.1 mg

Max: 0.3 mg QD

Mineralocorticoid increase blood volume. Enhances sensitivity to circulating catecholamines

Edema

HTN

HypoK

Do not use in CHF

Midodrine

2.5mg TID

↑ by 2.5mg

Up to 10mg TID

Peripheral-selective α1 agonist → constricts both aa & vv

Supine HTN

Pilomotor reactions

Pruritus

GI upset

Avoid in uncontrolled HTN, urinary retention, heart disease

Droxidopa

100mg

↑ by 100mg

Up to 600mg TID

NE precursor → carboxylated to NE. Can cross BBB. Supine HTN, less than midodrine
Atomoxetine 10mg or 18mg SNRI Do not use w/ glaucoma or MAOI
  • Supine HTN therapies: transdermal nitroglycerin (preferred); minoxidil, hydralazine, or clonidine in select patients